lopinavir/ritonavir / Generic mfg. 
Welcome,         Profile    Billing    Logout  

12 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lopinavir/ritonavir / Generic mfg.
2011-003447-21: Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxis

Ongoing
4
280
Europe
Maraviroc, Celsentri, Celsentri
Camden Provider Services, Pfizer
Prophylaxis and prevention of HIV Infection.
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2020-001366-11: An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care Un ensayo aleatorizado internacional para evaluar tratamientos no licenciados para COVID-19 en pacientes hospitalizados que reciben el tratamiento convencional para COVID que se ofrece en cada hospital

Ongoing
3/4
100000
Europe
Remdesivir, Lyophilisate for solution for infusion, Tablet, , Chloroquine, HYDROXYCHLOROQUINE SULFATE, Lopinavir/Ritonavir, Interferón b 1A
FIB-HCSC, WHO (World Health Organization), Vilnius University Hospital Santaros Klinikos, World Health Organisation, Department of Health, AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA, AICIB, Ministerstvo Zdravotníctva Slovenskej republiky, World Health Organization, Ministry of Health, Ministry of Health of the Republic of Latvia, FIB-HCSC, Vilnius University Hospital Santaros Klinikos, World Health Organisation, Department of Health, WHO, AICIB, Ministerstvo zdravotníctva Slovenskej republiky, World Health Organization, Ministry of Health, Ministry of Health of Latvia, Ministry of Health of the Republic of Latvia
COVID-19 COVID-19, COVID-19 COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
2020-002060-31: An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care Mezinárodní randomizovaná studie další léčby COVID-19 u hospitalizovaných pacientů, kteří jsou léčeni standardní péčí.

Ongoing
3
100000
Europe
remdesivir, Lyophilisate for solution for infusion, Coated tablet, Powder and solution for solution for injection, Kaletra, Rebif, Plaquenil
Masaryk University, World Health Organisation, Masaryk University
COVID-19 COVID-19, COVID-19 COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
NCT04403100: Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

Recruiting
3
1968
RoW
Hydroxychloroquine Sulfate Tablets, Lopinavir/ Ritonavir Oral Tablet, Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets, Placebo
Cardresearch, Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA, Cytel Inc.
COVID-19, Coronavirus Infection, Virus Disease, Acute Respiratory Infection, SARS-CoV Infection
02/21
02/21
NCT01338038: A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Recruiting
2/3
94
US, RoW
Lopinavir/ritonavir (LPV/r), Kaletra
International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Abbott
HIV Infection
12/13
01/14
2020-002106-68: FLARE: Favipiravir +/- Lopinavir: A RCT of Early antivirals

Ongoing
2
240
Europe
Favipiravir, Lopinavir/ritonavir, Tablet, Lopinavir/ritonavir
University College London Comprehensive Clinical Trial Unit, LifeArc
SARS-CoV-2 (Corona virus) infection, COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
NCT04390152: Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Recruiting
1/2
40
RoW
Wharton's jelly derived Mesenchymal stem cells., Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)
BioXcellerator, Clinical Somer
Acute Respiratory Distress Syndrome
12/21
04/22
ChiCTR2000029548: Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients

Not yet recruiting
N/A
30
China
BaloxavirMarboxil:80mg on day1,80mg on day4;and 80mg on day7 as neccessary. No more than 3 times administration in total.BaloxavirMarboxil:80mg on day1,80mg on day4;and 80mg on day7 as neccessary. No more than 3 times administration in total. ;Favipiravir: 600 mg tid with 1600mg first loading dosage for no more than 14 days. ;Lopinavir-Ritonavir: 2# (200mg/50 mg), twice daily, for 14days.
The First Affiliated Hospital, Zhejiang University School of Medicine; The First Affiliated Hospital, Zhejiang University School of Medicine, Self-financing
novel coronavirus pneumonia (COVID-19)
 
 
TARCoV, ChiCTR2000029468: A real-world study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19)

Not yet recruiting
N/A
120
China
Lopinavir/litonavir (LPV/r)+ emtritabine (FTC)/ Tenofovir alafenamide Fumarate tablets (TAF) in combination ;LPV/r
Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Department of science and technology of sichuan province (2020YFS0006)
novel coronavirus pneumonia (COVID-19)
 
 
POPS or POP02, NCT04278404: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Recruiting
N/A
5000
Canada, US
The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:, Aminocaproic acid, Amiodarone, Bosentan, Budesonide, Cefdinir, Cefepime, Ceftazidime, Clindamycin, Clobazam, Dexamethasone, Dexmedetomidine, Dextroamphetamine/Amphetamine, Fosfomycin, Furosemide, Gabapentin, Guanfacine, Hydrocortisone, Labetalol, Meropenem, Metformin, Milrinone, Nalbuphine, Nicardipine, Nifedipine, Oseltamivir, Oxycodone, Risperidone, Sertraline, Sevelamer Carbonate / Sevelamer Hydrochloride, Spironolactone, Terbutaline, Tranexamic acid, Voriconazole, Zolpidem, Azithromycin, Lopinavir/Ritonavir, Ribavirin, Tocilizumab, Anakinra, Aspirin, Canakinumab, Colchicine, Interferon, Remdesivir, Ruxolitinib, Sarilumab, Abatacept, Infliximab
Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema, Hypokalemia, Heart Failure, Hemophilia, Menorrhagia, Insomnia, Pneumonia, Skin Infection, Arrythmia, Asthma in Children, Bronchopulmonary Dysplasia, Adrenal Insufficiency, Fibrinolysis; Hemorrhage, Attention Deficit Hyperactivity Disorder, Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coagulation Disorder, Down Syndrome
09/26
09/27
NCT04518228: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

Recruiting
N/A
325
US, RoW
Bictegravir (BIC), Tenofovir alafenamide (TAF), Cabotegravir (CAB), Dolutegravir (DTG), Atazanavir/ritonavir (ATV/r), Darunavir/ritonavir (DRV/r), Lopinavir/ritonavir (LPV/r), Cobicistat, Ritonavir, First-Line TB Treatment, Second-Line TB Treatment, Doravirine (DOR)
National Institute of Allergy and Infectious Diseases (NIAID), International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme LLC
HIV Infections, Tuberculosis
03/26
03/26

Download Options